Fumaric Acid

Fumaric Acid

SCHEMBL9209072

Cc1c(C(C)C)c(=O)oc2c(C)c(OCC3CNCCO3)ccc12.O=C(O)C=CC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A known ✓ P28223 3/20 0.41
▸ SLC6A4 known ✓ P31645 3/20 0.41
▸ ADRB2 known ✓ P07550 1/20 0.41
▸ HTR1A known ✓ P08908 1/20 0.41
▸ SLC6A2 known ✓ P23975 1/20 0.41
▸ ADRA1A known ✓ P35348 1/20 0.41
▸ HTR2B known ✓ P41595 1/20 0.41
▸ SLC6A3 known ✓ Q01959 1/20 0.41
▸ ADRA2C known ✓ P18825 1/20 0.41
▸ KMT2A known ✓ Q03164 2/20 0.38
▸ MEN1 known ✓ O00255 1/20 0.38
▸ IRAK4 Q9NWZ3 6/20 0.41
▸ FHIT P49789 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9209066 1.00 HTR2A (0.41) HTR2ASLC6A4ADRB2HTR1ASLC6A2
SCHEMBL9209696 0.93 HTR2A (0.47) HTR2ASLC6A4ADRB2HTR1ASLC6A2
SCHEMBL9209645 0.83 HTR2A (0.52) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Hydrochloric Acid SCHEMBL9212821 0.82 HTR2A (0.51) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Hydrochloric Acid SCHEMBL9212810 0.82 HTR2A (0.51) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Hydrochloric Acid SCHEMBL9213650 0.82 HTR2A (0.51) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Hydrochloric Acid SCHEMBL9211654 0.79 HTR2A (0.47) HTR2ASLC6A4ADRB2HTR1ASLC6A2
SCHEMBL9214026 0.76 KDM4E (0.52) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Hydrochloric Acid SCHEMBL9218819 0.75 KDM4E (0.51) HTR2ASLC6A4ADRB2HTR1ASLC6A2
SCHEMBL9214012 0.73 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0411912-B1 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders SANKYO CO (JP) 1995-04-19 — — EP disclosed
EP-0411912-A2 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders Sankyo Company Limited (JP) 1991-02-06 — — EP disclosed
Send feedback